Medipharm Labs Sees CEO Pat McCutcheon Step Down From Role, Remain As Chairman

Medipharm Labs (TSX: LABS) this morning announced drastic changes to its leadership role, with the major change being that CEO Pat McCutcheon will be stepping down from his role as CEO, with no permanent replacement named. The result will be that the company will have both an interim CFO and an interim CEO helming the company.

The leadership changes announced this morning are reportedly to “prepare the company for its next phase of growth,” while also focusing on that of efficiency and cost savings. Taking McCutcheon’s role on an interim basis will be that of Keith Stratchan. McCutcheon meanwhile will be remaining with the company in the role of Chairman of the board.

Also outlined this morning is that Warren Everitt will remain as CEO of the Asia Pacific region for the company, while Olga Utkutug has been named as the interim CFO of the company, effective December 8, 2020. The company has yet to find a permanent replacement since Bobby Kwon resigned from the company, effective at the end of November.

The company is said to immediately begin the process of finding a permanent CEO replacement, while that process is already underway for the role of CFO.

Medipharm Labs last traded at $0.55 on the TSX.


.Information for this briefing was found via Sedar and Medipharm Labs. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Is Gold’s Bull Market About to Hit Junior Stocks? | Ken Armstrong – Westhaven Gold

Surge Battery Metals: The Nevada North Lithium PEA

Silver @ $36 & We’re Still 200M Oz Short | Paul Andre Huet – Americas Gold and Silver

Recommended

Goliath Resources Closes Out Funding Round With Total Gross Proceeds Of $27.1 Million

Silver47 Kickstarts 4,000 Metre Drill Campaign At Red Mountain Project

Related News

Medipharm Labs Files Statement Of Claim Against Undisclosed Producer

Medipharm Labs (TSX: LABS) issued a typical Friday evening release today, identifying that the company...

Friday, January 24, 2020, 05:34:50 PM

Medipharm Labs Ships First Topical Products

Medipharm Labs (TSX: LABS) is now in the cannabis topicals business. The company announced this...

Wednesday, March 25, 2020, 08:20:53 AM

Hexo Has Filed A $35 Million Counterclaim Against Medipharm Labs

It appears that Hexo Corp (TSX: HEXO) (NYSE: HEXO) has filed a counterclaim against Medipharm...

Thursday, June 18, 2020, 11:48:39 AM

Champignon Brands Appoints Medipharm Labs CEO Pat McCutcheon to Board

This morning Champignon Brands Inc. (CSE: SHRM) announced the appointment of Pat McCutcheon to its...

Wednesday, May 6, 2020, 09:18:25 AM

Rough Week In Cannabis Sector Capped With Gut Punch From Ontario

This first week of April has been the never-ending week for the cannabis industry that...

Friday, April 3, 2020, 03:24:27 PM